2. As of noon trading, Edwards Life ( EW) is down $1.79 (-2.2%) to $79.42 on heavy volume Thus far, 927,661 shares of Edwards Life exchanged hands as compared to its average daily volume of 954,300 shares. The stock has ranged in price between $79.30-$81.37 after having opened the day at $81.14 as compared to the previous trading day's close of $81.21.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Life has a market cap of $9.4 billion and is part of the health services industry. The company has a P/E ratio of 33.1, above the S&P 500 P/E ratio of 17.7. Shares are down 9.9% year to date as of the close of trading on Monday. Currently there are 9 analysts that rate Edwards Life a buy, 2 analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Edwards Life as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Edwards Life Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you liked this article you might like

Clovis Spikes on Phase 3 Data for Ovarian Cancer Drug- Biotech Movers

Cramer: There Should Be More Takeovers Where These Came From

Otonomy Shares Fall On Disappointing Phase 3 Data - Biotech Movers

Eli Lilly Shares Lower After Update on Rheumatoid Arthritis Drug

How Competition Drives Stocks Nowhere: Cramer's 'Mad Money' Recap (Tuesday 7/11/17)